TGFβ1 Cell Cycle Arrest Is Mediated by Inhibition of MCM Assembly in Rb-Deficient Conditions

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Transforming growth factor β1 (TGFβ1) is a known cell growth inhibitor.
• TGFβ1 employs multiple mechanisms to induce cell-cycle arrest, including targeting gene regulation and CDC45-MCM-GINS (CMG) helicase function.
• Canonical TGFβ1 pathways involve the retinoblastoma (Rb) tumor suppressor and impact MCM subunit expression and CMG assembly.

Purpose of the Study:

• To investigate the mechanisms of TGFβ1-induced cell-cycle arrest in Rb-deficient cells.
• To identify novel targets and pathways through which TGFβ1 mediates growth inhibition.
• To elucidate the role of MCM assembly in TGFβ1-induced cell-cycle arrest.

Main Methods:

• Utilized Rb-deficient cell models to study TGFβ1 signaling.
• Assessed the impact of TGFβ1 on Myc, Cyclin E/Cdk2 activity, and MCM expression.
• Investigated MCM hexamer assembly, Cyclin E-Mcm7 interaction, and CDT1 function.
• Analyzed Smad2/3/4 dependency and CDT1 overexpression effects.

Main Results:

• In Rb-deficient cells, TGFβ1 still induced cell-cycle arrest dependent on Smad2/3/4, despite intact Myc, Cyclin E/Cdk2, and MCM expression.
• TGFβ1 inhibited MCM hexamer assembly by blocking the Cyclin E-Mcm7 interaction, a mechanism distinct from Rb-mediated inhibition of MCM expression.
• Overexpression of CDC10-dependent transcript-1 (CDT1) with an intact MCM-binding domain abrogated TGFβ1-induced arrest and rescued MCM assembly.

Conclusions:

• MCM assembly is a critical target for TGFβ1-mediated cell-cycle arrest, particularly in the absence of Rb.
• TGFβ1 inhibits MCM assembly through disruption of the Cyclin E-Mcm7 interaction, upstream of CDT1 function.
• CDT1 plays a role in abrogating TGFβ1's inhibition of MCM assembly, suggesting a potential oncogenic function.